December 20, 2014 9:12 PM ET

Pharmaceuticals

Company Overview of Intersect ENT, Inc.

Company Overview

Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug-eluting implants for patients undergoing sinus surgery to treat chronic sinusitis. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November, 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.

1555 Adams Drive

Menlo Park, CA 94025

United States

Founded in 2003

179 Employees

Phone:

650-641-2100

Fax:

866-736-1251

Key Executives for Intersect ENT, Inc.

Chief Executive Officer
Age: 44
Total Annual Compensation: $334.8K
Chief Operating Officer and Senior Vice President
Age: 52
Total Annual Compensation: $293.2K
Vice President of Sales
Age: 44
Total Annual Compensation: $154.5K
Compensation as of Fiscal Year 2013.

Intersect ENT, Inc. Key Developments

Intersect ENT, Inc. Announces Board Changes, Effective December 15, 2014

On December 8, 2014, Rick D. Anderson tendered his resignation as a member of the Board of Directors of Intersect ENT, Inc., as a member of the Audit Committee of the Board, and as a member and the chairperson of the Nominating and Corporate Governance Committee of the Board, effective December 15, 2014. On December 9, 2014, the Board appointed Frederic H. Moll as a member of the Audit Committee of the Board to fill the vacancy created by Mr. Anderson's resignation. On December 8, 2014, Mark Fletcher tendered his resignation as a member of the Board of Intersect, effective December 15, 2014.

Intersect ENT, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 03:00 PM

Intersect ENT, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 03:00 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Intersect ENT, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM

Intersect ENT, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM. Venue: The Westin Grand Central, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Oculex Pharmaceuticals, Inc. United States
Ceva Biomune United States
Orphagen Pharmaceuticals, Inc. United States
G2B Pharma, Inc. United States
AnazaoHealth United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intersect ENT, Inc., please visit www.intersectent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.